Description of the technique
Laser therapy uses infrared electromagnetic energy that penetrates the body in the form of photons. A beam of light consisting of photons remains narrow enough and does not scatter like the light of an ordinary lamp. It has good focusing, which allows you to achieve high energy density. The depth and volume of penetration of this photonic energy depend on a number of factors.
Studies show that tissues exposed to high-intensity laser therapy are stimulated to increase the production of a cellular enzyme (Cytochrome C Oxidase), which plays a key role in the production of ATP. ATP is the main source of chemical energy in living cells. With an increase in ATP production and, accordingly, with an increase in cellular energy, various biological processes are activated, such as anesthesia, reduction of inflammation, resorption of scar tissue, acceleration of cellular metabolism, improvement of vascular activity and accelerated healing. This is the photochemical effect of high-intensity laser therapy.
Biological effects of laser therapy
Areas of application
Comparison
Additional information
Explanation of Indicators and Technologies: YAG or Diode - Which to Choose?
The penetration of a laser beam into tissue depends on several factors, including the wavelength and how the emission interacts with tissues. Laser emission travels through tissues until it is either absorbed or scattered. Different wavelengths penetrate to varying depths. Body tissues contain various components (water, hemoglobin, melanin), which absorb light at different wavelengths in different ways.
Each of these wavelengths allows for targeting different tissue depths, enabling treatment of both superficial and deep damage depending on the combination of wavelengths used.
Simultaneous use of different wavelengths provides a variety of effects and more comprehensive treatment, targeting various tissue layers. Combining different wavelengths allows for both deep and superficial impact, which can be beneficial for treating complex or multi-layered injuries. This combination reduces treatment time by covering both superficial and deep tissue layers.
Limitations of the 1064 nm laser for superficial tissues: Due to its deep penetrating ability, the 1064 nm monomodal laser may be less effective for treating superficial injuries and conditions, as its energy penetrates too deeply to affect the surface layers of the skin and tissues adequately. There is a risk of overheating the tissues, potentially causing damage as a result.
A diode laser uses a semiconductor diode as a emission source. This diode converts electrical energy directly into light energy. Diode lasers are generally compact, efficient, and can operate at various wavelengths.
The YAG laser uses a yttrium aluminum garnet (YAG) crystal doped with rare earth elements (e.g. neodymium, Nd). The crystal is excited by an external light source, which causes the generation of laser emission at a wavelength of 1064 nm.
Pre-installed Protocols (100+). You can also create and save your own preferred settings and patient profiles for quick access. The system supports "unattended" mode, where everything is automatically controlled via a wireless switch during the procedure. The "unattended" mode allows remote control of the device and the process.
Diode lasers can emit light at various wavelengths, depending on the diode material. These wavelengths can range from infrared to visible spectrums.
YAG lasers typically operate at a fixed wavelength of 1064 nm (infrared spectrum).
Diode lasers are generally more efficient in converting electrical energy into light and can operate at lower power levels, making them energy-efficient and portable. They usually require less cooling as they are less prone to overheating due to their high energy efficiency.
YAG lasers, on the other hand, can generate very high power and consume more energy. As a result, YAG lasers require more advanced cooling systems, especially when operating at high power levels, to prevent overheating of the crystal and other components.
YAG lasers also demand more precise control to avoid overheating and damaging deep tissues. This is particularly important when treating patients recovering from severe injuries. They may require more fine-tuning and staff training, which can limit their use in situations where quick intervention is needed.
Most therapeutic laser devices currently in use are known as "cold lasers". These lasers have very low power, and therefore do not generate heat on the skin. Treatment using these lasers is called "low intensity laser therapy" (LLLT).
The Klinogicare® Beam Ultra Power Physio Laser 45W portable laser is a "hot laser". It is much more powerful than cold lasers, as a rule - more than 150 times. Therapy using Klinogicare® feels warm and soothing due to its greater energy. This type is called "high intensity laser therapy" (HILT).
Both types of lasers, both hot and cold, have a similar penetration depth into the body. The depth of penetration is determined by the wavelength of the light, not the power. The difference between them lies in the time required to deliver a therapeutic therapeutic dose. A hot hot laser can treat an arthritic knee to achieve an analgesic effect in about 4 minutes. A cold laser will take 16 hours to deliver the same dose.
Scientific research
Abstract
Low back pain (LBP) is a widespread health issue affecting people globally and is the second leading cause of missed workdays. High-intensity laser therapy (HILT) promises to decrease pain intensity in LBP patients. The aim of this work was to evaluate the effect of HILT in adult LBP patients. We searched for randomized controlled studies (RCTs) published before January of 2023. Our primary outcome was pain intensity, while our secondary outcomes included disability and flexibility scores. We synthesized the evidence using RevMan v.5.4 and assessed methodological quality with the Oxford/Jadad scale and the Cochrane collaboration's risk of bias tool 1. The model favors the HILT group over the control group in terms of pain intensity after treatment (MD with 95% CI is -1.65 [-2.22, -1.09], p-value < 0.00001, I2=67%), Oswestry disability index (MD with 95% CI is -0.67 [-1.22, -0.12], p-value = 0.02, I2=73%), and Roland disability index (MD with 95% CI is -1.36 [-1.76, -0.96], p-value <0.00001, I2=0%). The patients in the high-intensity laser therapy had statistically significantly lower (low back) pain intensity compared to the patients in the control group. Based on three RCTs, our model also showed the positive effect of the HILT on LBP in terms of the Oswestry disability index and Roland disability index.
Abstract
Objectives: The primary objective of this meta-analysis was to determine whether high-intensity laser therapy (HILT) was effective in improving pain intensity, cervical range of motion (ROM), functional activity, and quality of life (QOL) in individuals with neck pain.
Data sources: PubMed, PEDro, Embase, Cochrane Library, Web of Science, and ClinicalTrials.gov were searched from inception to March 26, 2022.
Study selection: Randomized controlled trials (RCTs) involving HILT for neck pain were selected.
Data extraction and data synthesis: Two raters were independent in data extraction. The methodological quality was evaluated using the PEDro scale, and the level of evidence was assessed using the GRADE system. RevMan5.4 was used for meta-analysis.
Results: Eight RCTs were included and their PEDro scores were moderate to high. Compared with placebo, HILT was effective in improving pain intensity (SMD 2.12, 95%CI 1.24 to 3.00; moderate quality evidence), cervical flexion (SMD 1.31, 95%CI 0.27 to 2.35; moderate quality evidence), extension (SMD 1.43, 95%CI 0.24 to 2.63; moderate quality evidence), right lateral flexion (SMD 1.36, 95%CI 0.15 to 2.56; low-quality evidence). There was a trend of better outcome in functional activity after HILT (SMD 1.73, 95%CI -0.05 to 3.54; low quality evidence).
Limitations: There was limited information available on QOL.
Conclusion: HILT may be considered as an adjunctive treatment modality for neck pain. There was moderate quality evidence that HILT may improve pain intensity and cervical ROM in individuals with neck pain, but there was low quality evidence that HILT was not effective in improving functional activity.
Link to the source |
Abstract
Objective
The purpose of this study was to research the clinical effectiveness of high-intensity laser therapy combined with exercise on pain, quality of life, and disability in patients with cervical radiculopathy and compared it with that of placebo and exercise alone.
Design
Ninety participants with cervical radiculopathy were randomized into the following three groups: high-intensity laser therapy + exercise (n = 30), placebo + exercise (n = 30), and exercise only (n = 30). Pain, cervical range of motion, disability, and quality of life (36-item Short Form Health Survey) were assessed at baseline and weeks 4 and 12.
Results
The mean age of the patients (66.7% female) was 48.9 ± 9.3 yrs. Pain intensity in the arm and neck, neuropathic and radicular pain levels, disability, and several parameters of the 36-item Short Form Health Survey showed an improvement in the short and medium term in all three groups. These improvements were greater in the high-intensity laser therapy + exercise group than in the other two groups.
Conclusions
High-intensity laser therapy + exercise was much more effective in improving medium-term radicular pain, quality of life, and functionality in patients with cervical radiculopathy. Thus, high-intensity laser therapy should be considered for the management of cervical radiculopathy.
Abstract
The purpose of this study is to evaluate the effects of high-intensity laser therapy (HILT) in patients with frozen shoulder. PRISMA guidelines were adhered to, and a systematic search was conducted in the PubMed, Web of Science, Scopus, CINAHL, Science Direct, and PEDro databases (last update: September 4, 2023; search period: December 2022-September 2023). The inclusion criteria encompassed RCTs comparing HILT with other physical therapy interventions in frozen patients with frozen shoulders, with or without sham HILT, assessing pain intensity, shoulder ROM, and disability outcomes. The quality of the RCTs was assessed with the Cochrane Risk of Bias tool, and evidence was assessed using the GRADE approach. Five trials met the eligibility criteria and were included in the review and meta-analysis, which pooled results from the visual analog scale (VAS), goniometry, and the shoulder pain and disability index (SPADI). Mean differences (MDs) for pain intensity and disability show a pooled effect in favor of HILT both for VAS (MD = - 2.23 cm, 95% CI: - 3.25, - 1.22) and SPADI (MD = - 10.1% (95% CI = - 16.5, - 3.7), changes that are statistical (p < 0.01) and clinical. The MD for flexion (MD = 9.0°; 95% CI: - 2.36°, 20.3°; p = 0.12), abduction (MD = 3.4°; 95% CI: - 6.9°, 13.7°; p = 0.51), and external rotation (MD = - 0.95°; 95% CI: - 5.36°, 3.5°; p = 0.67) does not show statistical and clinical differences between groups after treatment. PI and disability changes were graded as important due to their clinical and statistical results. HILT into a physical therapy plan reduce pain and disability, but it does not outperform conventional physical therapy in improving shoulder ROM. It is suggested that future RCTs compare the effects of HILT and LLLT to assess their possible differences in their analgesic effects.